IGEA Pharma N.V. Becomes the 12th New Listing at SIX in 2018

Today, the shares of IGEA Pharma N.V. (IGPH) were listed under the “International Reporting Standard” on the Swiss Stock Exchange.

Published at
Medium
Media

The share capital of IGEA Pharma N.V. comprises 25,048,769 shares with a nominal value of EUR 0.01 each. The opening price was CHF 3.75 per share, corresponding to a market capitalization of around CHF 94 million. An offering of the company’s shares has not taken place.

IGEA Pharma N.V. is a life sciences company with its corporate headquarters in Amsterdam in the Netherlands. The IGEA Group focuses on products and services related to the prevention of Alzheimer's and Type II Diabetes. For more information on the company, please visit: www.igeapharma.nl

Any questions?

Please do not hesitate to contact Julian Chan.

Generate PDF

 
About SIX
SIX provides and operates stable and efficient infrastructure for the Swiss and Spanish financial centers, thus ensuring access to the capital markets and the flow of information and money between financial market players. As a global provider of financial information, SIX delivers high-quality reference, pricing, corporate actions, and ESG data and provides regulatory services and indices to clients around the world. The company is owned by its users (more than 120 banks) with a workforce of 4,160 employees and a presence in 19 countries.
www.six-group.com

View all Media Releases